Sareum plc, a specialist cancer drug discovery business, has raised £815,000 in a series of placings over the past month.
Tim Mitchell, Founder and CEO, who rescued some of the company’s programmes and re-established the company said the funding, “Will enable us to progress our cancer research programmes for the foreseeable future. We are delighted with this support from investing institutions.”
Follow where the public and private R&I money is going and which collaborative opportunities you can pursue.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
Sign up for the Funding Newswire
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
